Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Return on Equity (2017 - 2020)

Historic Return on Equity for Forte Biosciences (FBRX) over the last 4 years, with Q3 2020 value amounting to 0.88%.

  • Forte Biosciences' Return on Equity rose 16900.0% to 0.88% in Q3 2020 from the same period last year, while for Sep 2020 it was 0.88%, marking a year-over-year increase of 16900.0%. This contributed to the annual value of 2.38% for FY2019, which is 16200.0% down from last year.
  • Forte Biosciences' Return on Equity amounted to 0.88% in Q3 2020, which was up 16900.0% from 2.87% recorded in Q2 2020.
  • Over the past 5 years, Forte Biosciences' Return on Equity peaked at 41.55% during Q1 2020, and registered a low of 8.45% during Q4 2019.
  • Moreover, its 4-year median value for Return on Equity was 0.88% (2020), whereas its average is 1.46%.
  • Per our database at Business Quant, Forte Biosciences' Return on Equity plummeted by -75300bps in 2019 and then surged by 425900bps in 2020.
  • Forte Biosciences' Return on Equity (Quarter) stood at 0.52% in 2017, then plummeted by -80bps to 0.93% in 2018, then crashed by -813bps to 8.45% in 2019, then skyrocketed by 90bps to 0.88% in 2020.
  • Its last three reported values are 0.88% in Q3 2020, 2.87% for Q2 2020, and 41.55% during Q1 2020.